Aviso Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-215
Closed -$5.18K – 282
2026
Q2
$5.18K Buy
+215
New +$5.62K ﹤0.01% 248
2025
Q2
– Sell
-128
Closed -$3.24K – 364
2025
Q1
$3.24K Buy
+128
New +$3.35K ﹤0.01% 320
2024
Q4
– Sell
-29,360
Closed -$850K – 383
2024
Q3
$850K Buy
29,360
+2,030
+7% +$59.2K 0.04% 158
2024
Q2
$765K Buy
+27,330
New +$752K 0.04% 162

Other funds holding PFE

Aviso Financial's PFE Position: Q3 2026 in Review

Aviso Financial sold out of Pfizer (PFE) in Q3 2026, closing a stake of 215 shares — an estimated $5.18K sold.

Aviso Financial first reported a position in PFE in Q2 2024 and held it in 4 quarters. The position peaked at $850K in Q3 2024. 2,712 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Aviso Financial reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • Aviso Financial sold 215 Pfizer shares in Q3 2026, an estimated $5.18K.
  • Aviso Financial first reported a position in Pfizer in Q2 2024 and held it in 4 quarters.
  • Aviso Financial's Pfizer position peaked at $850K in Q3 2024.
  • 2,712 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Aviso Financial's 13F filing for Q3 2026, filed 12 Nov 2026.